Expert Opinion on Therapeutic Targets, Volume 25, Issue 10 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 25, Issue 10 (2021)

See all volumes and issues
Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Volume 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997
Download citations Download PDFs Download issue

Review

Novel immune targets for the treatment of triple-negative breast cancer
Chiara Corti, Eleonora Nicolò & Giuseppe Curigliano
Pages: 815-834
Published online: 25 Nov 2021
AbstractforNovel immune targets for the treatment of triple-negative breast cancer | Full Text | References | PDF (1.9 MB) | EPUB
  • 564 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Cholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells?
Juan Wang, Emilien Loeuillard, Gregory J. Gores & Sumera I. Ilyas
Pages: 835-845
Published online: 03 Dec 2021
AbstractforCholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells? | Full Text | References | PDF (2.4 MB) | EPUB
  • 418 Views
  • 3 CrossRef citations
  • 0Altmetric
Retinal vein occlusion: drug targets and therapeutic implications
Alessandro Arrigo & Francesco Bandello
Pages: 847-864
Published online: 07 Dec 2021
AbstractforRetinal vein occlusion: drug targets and therapeutic implications | Full Text | References | PDF (4.1 MB) | EPUB
  • 238 Views
  • 5 CrossRef citations
  • 0Altmetric
NRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows
Domenico Trombetta, Angelo Sparaneo, Federico Pio Fabrizio, Concetta Martina Di Micco, Antonio Rossi & Lucia Anna Muscarella
Pages: 865-875
Published online: 18 Nov 2021
AbstractforNRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows | Full Text | References | PDF (3.8 MB) | EPUB
  • 416 Views
  • 4 CrossRef citations
  • 0Altmetric
Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson’s disease
Fanni Annamária Boros & László Vécsei
Pages: 877-888
Published online: 26 Nov 2021
AbstractforTryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson’s disease | Full Text | References | PDF (519.4 KB) | EPUB
  • 290 Views
  • 2 CrossRef citations
  • 0Altmetric
A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)
Stuart K Roberts & Ammar Majeed
Pages: 889-895
Published online: 18 Nov 2021
AbstractforA short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH) | Full Text | References | PDF (675.2 KB) | EPUB
  • 262 Views
  • 6 CrossRef citations
  • 0Altmetric
Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies
Sunghark Kwon & So Yeong Cheon
Pages: 897-907
Published online: 26 Nov 2021
AbstractforInfluence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies | Full Text | References | PDF (1.7 MB) | EPUB
  • 213 Views
  • 1 CrossRef citations
  • 0Altmetric

Correspondence

Article
Role of hemagglutinin esterase in replication of SARS-CoV-2
Milad Zandi, Saber Soltani & Parastoo Hosseini
Page: 909
Published online: 18 Nov 2021
CitationforRole of hemagglutinin esterase in replication of SARS-CoV-2 | Full Text | References | PDF (91.8 KB) | EPUB
  • 665 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Correspondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
Dhriti Kaushik, Ranjana Bhandari & Anurag Kuhad
Page: 911
Published online: 28 Nov 2021
CitationforCorrespondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2 | Full Text | References | PDF (125.2 KB) | EPUB
  • 628 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles